romcomics

Innovative Alzheimer’s Disease Combination Therapy Trial Supported By New Joint Funding Initiative

on October 24, 2017 Press Releases with 0 comments

October 24, 2017 08:00 AM Eastern Daylight Time NEW YORK AND CHICAGO, Oct. 24, 2017 /PRNewswire-USNewswire/ — The Alzheimer’s Association and Alzheimer’s Drug Discovery Foundation (ADDF) are collaborating to jointly fund a new combination therapy clinical trial for Alzheimer’s disease to be conducted by Amylyx Pharmaceuticals. The $1.85 million grant is the first award under an initiative created by the Alzheimer’s Association […]

Read more

Amylyx Pharmaceuticals Receives FDA Orphan Drug Designation for AMX0035 for the Treatment of Amyotrophic Lateral Sclerosis

on September 19, 2017 Press Releases with 0 comments

September 19, 2017 09:00 AM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Amylyx Pharmaceuticals, Inc., announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to AMX0035, an oral therapeutic in clinical development for the treatment of amyotrophic lateral sclerosis (ALS). The Company recently began a Phase 2 clinical study, the CENTAUR […]

Read more

Project ALS and Amylyx Enter Collaboration to Test AMX0035

on September 7, 2017 Press Releases with 0 comments

Pre-clinical studies at Columbia University’s Motor Neuron Center Complement Amylyx Phase 2 Clinical Studies of Lead Therapeutic Compound New York, NY and Cambridge, MA (September 7, 2017) – Project ALS and Amylyx Pharmaceuticals today announced a collaboration to undertake pre-clinical studies with Amylyx’s oral compound AMX0035 to advance the understanding of the compound’s neurobiological effects. […]

Read more

Amylyx Pharmaceuticals Doses First Patient in Phase II Clinical Trial of AMX0035 for the Treatment of Amyotrophic Lateral Sclerosis

on August 8, 2017 Press Releases with 0 comments

Cambridge, MA, August 8, 2017 – Amylyx Pharmaceuticals, Inc., in collaboration with The ALS Association, ALS Finding a Cure®, and the Massachusetts General Hospital, today announced that the first patient was dosed in the CENTAUR study, a Phase II clinical trial assessing the efficacy and safety of AMX0035 for the treatment of amyotrophic lateral sclerosis […]

Read more

Amylyx Announces $5 Million Series A Financing to Support Phase II Clinical Trial of AMX0035 for Treatment of Amyotrophic Lateral Sclerosis

on August 22, 2016 Press Releases with 0 comments

Amylyx Announces $5 Million Series A Financing to Support Phase II Clinical Trial of AMX0035 for Treatment of Amyotrophic Lateral Sclerosis Cambridge, Mass. (August 22, 2016) — Amylyx Pharmaceuticals Inc. announced today that it has completed a $5 million Series A financing to support its upcoming Phase II trial in patients with Amyotrophic Lateral Sclerosis […]

Read more

The ALS Association and ALS Finding a Cure Announce Joint Funding Support for Amylyx Clinical Trial of AMX0035 for the Treatment of ALS

on July 20, 2016 Press Releases with 0 comments

The ALS Association and ALS Finding a Cure Announce Joint Funding Support for Amylyx Clinical Trial of AMX0035 for the Treatment of ALS July 20, 2016 08:00 AM Eastern Standard Time Washington, D.C. and Cambridge, Mass. (July 20, 2016) — The ALS Association and Amylyx Pharmaceuticals based in Cambridge, Mass. are pleased to announce that […]

Read more

Amylyx Announces Election of Nobel Laureate Walter Gilbert, PhD, to Board of Directors

on January 19, 2016 Press Releases with 1 comment

Amylyx Announces Election of Nobel Laureate Walter Gilbert, PhD, to Board of Directors | Business Wire January 19, 2016 10:00 AM Eastern Standard Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Amylyx Pharmaceuticals, a privately-held pharmaceutical company focused on disease-modifying treatments for Amyotrophic Lateral Sclerosis (ALS) and other neurodegenerative diseases, today announced the election of Nobel Laureate and former Biogen […]

Read more

Amylyx Announces Support from the ALS Finding a Cure Foundation and the Cure Alzheimer’s Fund to Bring a New Treatment for Amyotrophic Lateral Sclerosis to Clinical Trials

on November 17, 2015 Press Releases with 0 comments

Amylyx Announces Support from the ALS Finding a Cure Foundation and the Cure Alzheimer’s Fund to Bring a New Treatment for Amyotrophic Lateral Sclerosis to Clinical Trials Novel therapeutic blocks nerve cell death and inflammation Clinical trials slated for 2016 Cambridge, MA, November 17, 2015 – Amylyx Pharmaceuticals today announced it has received $600,000 from […]

Read more